MUC1 is an interesting target for antibody-based anti-cancer therapy, as it is expressed by a wide variety of tumors, including breast, ovarian, lung, colon, and pancreatic carcinomas as well as multiple myeloma [14]. This evidence concerns the gene MUC1 and exocrine pancreatic carcinoma.